Therapeutic strategies based on immunological hypotheses of Alzheimer’s disease
There are several findings demonstrating the importance of inflammatory or immunological processes in the etiopathogenesis of Alzheimer’s disease (AD).
Several studies on nonsteroidal anti-inflammatory drugs (NSAID) give evidence for a therapeutic effect of these drugs in AD, among other the prospective double-blind placebo-controlled study on indomethacin, strongly support the therapeutic effect of these agents. Possibly also the therapeutic effects of propentofylline might be interpreted in the light of this theory.
KeywordsAlzheimer Disease Human Astrocytoma Cell Severe Behavioral Problem Vascular Dementia Group Mental Status Test
Unable to display preview. Download preview PDF.
- Breteler MM, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, et al (1991) Medical history and the risk of Alzheimer’s disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20 [Suppl 2]: S36–42CrossRefGoogle Scholar
- Rogers J, O’Barr S (1997) Inflammatory mediators in Alzheimer’s disease. In: Wasco W, Tanzi RE (eds) Molecular mechanisms of dementia. Humana Press, Totowa New Jersey, pp 177–98Google Scholar